Skip to content
S2

Study 200195 App for Android APK

Publisher: GSK Studio
Android APK Free
File typeAPK
Version2.29.98
Publisher GSK Studio
Release dateSep 14, 2018
Date addedSep 14, 2018
Os requirementsAndroid
RequirementsNone
Total downloads0
PriceFree

Description

Study 200195 App's purpose is to support GSK Study 200195 (Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated with Strimvelis (or GSK269273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness). Registry participant's will be able to use the app to enter the required information for the study.

Similar programs

Alternatives